We are extremely short staffed due to the pandemic and are experiencing high call volumes. Please send us a message through our patient portal and we will get back to you as quickly as we can. Thank you for your understanding.

Myelodysplastic Syndromes Treatment Options

De Novo and Secondary Myelodysplastic Syndromes

Treatment of de novo and secondary myelodysplastic syndromes may include the following:

  • Supportive care with transfusion therapy
  • High-dose chemotherapy with stem cell transplant using stem cells from a donor
  • Supportive care with growth factor therapy
  • Chemotherapy with azacitidine, decitabine, or other anticancer drugs
  • Supportive care with drug therapy
  • A clinical trial of a new anticancer drug
  • A clinical trial of low-dose chemotherapy with stem cell transplant using stem cells from a donor
  • A clinical trial of a combination of treatments
  • A clinical trial of growth factor therapy

Previously Treated Myelodysplastic Syndromes

Treatment of previously treated myelodysplastic syndromes may include the following:

  • High-dose chemotherapy with stem cell transplant using stem cells from a donor
  • Chemotherapy with azacitidine or decitabine
  • Supportive care with transfusion therapy, growth factor therapy, and/or drug therapy
  • A clinical trial of low-dose chemotherapy with stem cell transplant using stem cells from a donor
  • A clinical trial of new drug therapy
  • A clinical trial of a combination of treatments
  • A clinical trial of growth factor therapy